U.S. Physical Therapy’s (USPH) Buy Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald restated their buy rating on shares of U.S. Physical Therapy (NYSE:USPH) in a research report sent to investors on Tuesday. They currently have a $80.00 price objective on the stock.

“After today’s market close, USPH released its preliminary estimates for the company’s 2018 consolidated tax rate; it estimates its effective rate will be within a range of 26-29%.”,” the firm’s analyst wrote.

Several other analysts also recently commented on USPH. Zacks Investment Research raised shares of U.S. Physical Therapy from a hold rating to a buy rating and set a $82.00 target price for the company in a report on Saturday, January 6th. BidaskClub raised shares of U.S. Physical Therapy from a strong sell rating to a sell rating in a report on Thursday, September 28th. Finally, Barrington Research downgraded shares of U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, November 3rd. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. U.S. Physical Therapy has an average rating of Buy and a consensus target price of $73.80.

Shares of U.S. Physical Therapy (NYSE:USPH) traded up $2.55 during mid-day trading on Tuesday, hitting $74.80. 43,100 shares of the company traded hands, compared to its average volume of 47,175. The company has a market cap of $942.96, a P/E ratio of 54.20, a price-to-earnings-growth ratio of 2.73 and a beta of 1.09. The company has a quick ratio of 2.04, a current ratio of 2.04 and a debt-to-equity ratio of 0.30. U.S. Physical Therapy has a 1-year low of $56.50 and a 1-year high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, November 2nd. The company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.04). The company had revenue of $103.03 million for the quarter, compared to the consensus estimate of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. equities research analysts anticipate that U.S. Physical Therapy will post 2.07 earnings per share for the current fiscal year.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 800 shares of U.S. Physical Therapy stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $69.21, for a total value of $55,368.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Christopher J. Reading sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $66.52, for a total transaction of $997,800.00. The disclosure for this sale can be found here. Insiders sold a total of 31,875 shares of company stock valued at $2,173,623 in the last quarter. Corporate insiders own 3.10% of the company’s stock.

Several large investors have recently modified their holdings of USPH. Sei Investments Co. raised its position in shares of U.S. Physical Therapy by 31.8% in the 2nd quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock valued at $155,000 after buying an additional 622 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in shares of U.S. Physical Therapy by 1.0% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 53,637 shares of the company’s stock valued at $3,240,000 after buying an additional 541 shares in the last quarter. Legal & General Group Plc raised its position in shares of U.S. Physical Therapy by 10.0% in the 2nd quarter. Legal & General Group Plc now owns 22,770 shares of the company’s stock valued at $1,374,000 after buying an additional 2,069 shares in the last quarter. BNP Paribas Arbitrage SA raised its position in shares of U.S. Physical Therapy by 66.5% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,106 shares of the company’s stock valued at $248,000 after buying an additional 1,640 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of U.S. Physical Therapy by 6.8% in the 2nd quarter. Victory Capital Management Inc. now owns 16,674 shares of the company’s stock valued at $1,007,000 after buying an additional 1,056 shares in the last quarter. Institutional investors own 94.12% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy’s (USPH) Buy Rating Reaffirmed at Cantor Fitzgerald” was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.themarketsdaily.com/2018/01/12/u-s-physical-therapys-usph-buy-rating-reaffirmed-at-cantor-fitzgerald.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply